MAP2K7 and neoplasm: Most importantly, we demonstrated that treatment with MEK inhibitors could enhance PpIX fluorescence selectively in tumours, but not in healthy tissues in mouse models of cancer, suggesting that MEK inhibition facilitates the preferential enhancement of PpIX accumulation in tumours.